title: Scaling in neurotrauma: how do we apply animal experiments to people?
abstract: Scaling is an essential component for translating the clinical outcomes of a neurotrauma model to the human equivalent. This article reviews the principles of biomechanical scaling for traumatic brain injuries, and a number of different approaches to scaling the dose (inputs) and response (outputs) of an animal model to humans are highlighted. A particular focus on blast injury scaling is given as an ongoing area of research, and discussion on the implications of scaling on the current blast TBI literature is provided. The risk of using neurotrauma models without considering an appropriate scaling method is that injuries may be induced with non-realistic loading conditions, and the injury mechanisms produced in the laboratory may not be consistent with those in the clinical setting.
authors.affiliation: Center for Applied Biomechanics, Dept. of Mechanical and Aerospace Engineering, University of Virginia, USA. Electronic address: panzer@virginia.edu.
authors.forename: Matthew B
authors.initials: MB
authors.lastname: Panzer
authors.affiliation: Dept. of Biomedical Engineering, Duke University, USA.
authors.forename: Garrett W
authors.initials: GW
authors.lastname: Wood
authors.affiliation: Dept. of Biomedical Engineering, Duke University, USA.
authors.forename: Cameron R
authors.initials: CR
authors.lastname: Bass
mesh_terms: D000818:Animals; D001753:Blast Injuries / Q000150:complications* / Q000473:pathology; D001921:Brain / Q000473:pathology*; D001930:Brain Injuries / Q000209:etiology* / Q000473:pathology; D004195:Disease Models, Animal; D006801:Humans
keywords: Biomechanics; Blast TBI; Neurotrauma; Scaling